LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DVD Technology-Based System Quickly and Inexpensively Detects SARS-CoV-2 Antigens and Specific Antibodies

By LabMedica International staff writers
Posted on 10 Feb 2021
A new DVD technology-based system quickly and inexpensively detects SARS-CoV-2 antigens and specific antibodies.

Researchers from the Polytechnic University of Valencia (Valencia, Spain) have developed a new system at laboratory scale that allows a rapid, cheap and effective detection of COVID-19. The system consists of a biosensor based on DVD technologies, that detects specific antibodies (G, M and A) and SARS-CoV-2 antigens - differentiating them to those of influenza - in a safe way, in less than 30 minutes, by analyzing serum or saliva samples. The price of the test is estimated at less than two Euros.

Image: DVD Technology-Based System Quickly and Inexpensively Detects SARS-CoV-2 Antigens and Specific Antibodies (Photo courtesy of Polytechnic University of Valencia)
Image: DVD Technology-Based System Quickly and Inexpensively Detects SARS-CoV-2 Antigens and Specific Antibodies (Photo courtesy of Polytechnic University of Valencia)

Called COMBO-SARS-CoV-2, the system can analyze up to a total of six serum and saliva samples simultaneously, determining type G, M and A antibodies and virus-specific antigens in less than half an hour. When a patient tests positive, the serological and/or saliva sample generates an optical signal that allows the identification of individuals who have suffered or are suffering the infection and establishes the concentration of the specific biomarkers. The COMBO-SARS-CoV-2 system can also be applied to detect other agents with infective capacity such as influenza viruses, adenoviruses and respiratory syncytial virus.

“The developed system will allow a rapid and automated viral diagnosis, at a much lower cost than the kits currently in use. Furthermore, these biosensors will enable a practical and efficient monitoring of the level of neutralizing antibodies once the vaccine is ready,” said Sergi Morais, Professor in the Department of Chemistry.

Related Links:
Polytechnic University of Valencia


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Microscope
dIFine
New
Automated PCR Setup
ESTREAM

Latest COVID-19 News

New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
10 Feb 2021  |   COVID-19

Long COVID Etiologies Found in Acute Infection Blood Samples
10 Feb 2021  |   COVID-19

Novel Device Detects COVID-19 Antibodies in Five Minutes
10 Feb 2021  |   COVID-19



PURITAN MEDICAL